Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Hodgkin Disease 65Lymphoma 39Urinary Bladder Neoplasms 16Carcinoma, Non-Small-Cell Lung 10Melanoma 9Lung Neoplasms 9Urethral Neoplasms 4Recurrence 4Prostatic Neoplasms 4Lymphoma, Large-Cell, Anaplastic 4Testicular Neoplasms 3Neoplasms 3Leukemia 3Glioma 3Central Nervous System Neoplasms 3Astrocytoma 3Testicular Germ Cell Tumor 2Teratoma 2Skin Neoplasms 2Oligodendroglioma 2Neurofibromatosis 1 2Kidney Neoplasms 2HIV Infections 2Carcinoma, Renal Cell 2Breast Neoplasms 2Brain Neoplasms 2Uterine Cervical Neoplasms 1Urothelial Carcinoma of the Bladder 1Ureteral Neoplasms 1Survival Without Progression 1

Interventions

Trastuzumab 597Paclitaxel 562Cyclophosphamide 545Docetaxel 479Capecitabine 388Letrozole 350Fulvestrant 311Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 177Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × Vinblastine × Clear all
NCT02299999 2025-01-15

SAFIR02_Breast

UNICANCER

Phase 2 Active not recruiting
1,460 enrolled
Breast

Breast Neoplasms

NCT04781725 2021-11-17

INVINCIBLE TRIAL: Intratumoral INT230-6 in Breast Cancer

Ottawa Hospital Research Institute

Phase 2 Unknown
90 enrolled
Breast

Pathologic Complete Response, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡